Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Novel insights into the molecular mechanisms of HLA class I abnormalities.

Seliger B.

Cancer Immunol Immunother. 2012 Feb;61(2):249-54. doi: 10.1007/s00262-011-1153-9. Epub 2011 Nov 27. Review.

PMID:
22120755
2.

The role of classical and non-classical HLA class I antigens in human tumors.

Bukur J, Jasinski S, Seliger B.

Semin Cancer Biol. 2012 Aug;22(4):350-8. doi: 10.1016/j.semcancer.2012.03.003. Epub 2012 Mar 24. Review.

PMID:
22465194
3.

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.

Seliger B.

Cancer Immunol Immunother. 2008 Nov;57(11):1719-26. doi: 10.1007/s00262-008-0515-4. Epub 2008 Apr 12. Review.

PMID:
18408926
4.

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

Atkins D, Ferrone S, Schmahl GE, Störkel S, Seliger B.

J Urol. 2004 Feb;171(2 Pt 1):885-9.

PMID:
14713847
5.

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.

Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.

Br J Dermatol. 2008 May;158(5):930-40. doi: 10.1111/j.1365-2133.2008.08465.x. Epub 2008 Feb 16.

PMID:
18284388
6.

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.

Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B.

Int J Oncol. 2001 Dec;19(6):1211-20.

PMID:
11713591
7.

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

Garrido F, Cabrera T, Aptsiauri N.

Int J Cancer. 2010 Jul 15;127(2):249-56. doi: 10.1002/ijc.25270. Review.

8.

The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.

Seliger B.

J Immunotoxicol. 2014 Oct;11(4):308-10. doi: 10.3109/1547691X.2013.875084. Epub 2014 Jan 30. Review.

PMID:
24479372
9.

Immune selection in murine tumors. Ph.d thesis.

Svane IM, Engel AM.

APMIS Suppl. 2003;(106):1-46.

PMID:
12739251
10.

Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.

Wang Z, Margulies L, Hicklin DJ, Ferrone S.

Tissue Antigens. 1996 May;47(5):382-90.

PMID:
8795138
11.

WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?

Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H.

Acta Neuropathol. 2007 Aug;114(2):111-9. Epub 2007 May 31.

PMID:
17541610
13.

Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.

Manning J, Indrova M, Lubyova B, Pribylova H, Bieblova J, Hejnar J, Simova J, Jandlova T, Bubenik J, Reinis M.

Immunology. 2008 Feb;123(2):218-27. Epub 2007 Aug 28.

14.

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.

Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B.

Clin Cancer Res. 2005 Apr 1;11(7):2552-60.

15.

Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.

Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C.

Tissue Antigens. 2000 Oct;56(4):327-36.

PMID:
11098932
16.

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Campoli M, Ferrone S.

Oncogene. 2008 Oct 6;27(45):5869-85. doi: 10.1038/onc.2008.273. Review.

17.

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.

Rodríguez T, Méndez R, Del Campo A, Jiménez P, Aptsiauri N, Garrido F, Ruiz-Cabello F.

BMC Cancer. 2007 Feb 23;7:34.

18.

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Romero JM, Jiménez P, Cabrera T, Cózar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F.

Int J Cancer. 2005 Feb 10;113(4):605-10.

19.

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

Algarra I, García-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F.

Cancer Immunol Immunother. 2004 Oct;53(10):904-10. Epub 2004 Apr 7. Review.

PMID:
15069585
20.

T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.

Mimura K, Ando T, Poschke I, Mougiakakos D, Johansson CC, Ichikawa J, Okita R, Nishimura MI, Handke D, Krug N, Choudhury A, Seliger B, Kiessling R.

Int J Cancer. 2011 Jan 15;128(2):390-401. doi: 10.1002/ijc.25613. Epub 2010 Oct 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk